Blood cancer patients are most vulnerable to COVID-19

Analysis of cancer types from the UK Coronavirus Cancer Monitoring Project (UKCCMP) suggests that patients with cancer may have different degrees of risk from COVID19 depending on their cancer type and age.  Further, patients with leukaemia, lymphoma and myeloma may be more likely to catch COVID-19 and develop a severe disease when comparing patients with…

Recent chemotherapy treatment doesn’t increase risk of dying from COVID-19 in cancer patients

First results from the UK Coronavirus Cancer Monitoring Project (UKCCMP) suggest that receiving chemotherapy treatment within four weeks prior to COVID-19 infection doesn’t increase the likelihood of dying.   The effect of cancer treatments Analysis of data gathered by the UKCCMP shows that cancer patients who received chemotherapy within four weeks before COVID-19 diagnosis were…

What we have learnt so far about cancer and COVID-19

The UK Coronavirus Cancer Monitoring Project has been collecting and analysing data from cancer patients with COVID-19 for seven weeks. Thanks to data from over 1,200 patients, we’re starting to gain new insight. Here’s what we’ve learned so far.   Younger patients do better Younger patients with cancer and COVID-19 are more likely to recover…

Why the UK Coronavirus Cancer Monitoring Project came to life

The UK Coronavirus Cancer Monitoring Project (UKCCMP) started as a direct response to the COVID-19 pandemic. It was up and running in record time, bringing the cancer community together to understand the impact of coronavirus on cancer patients. Dr Karin Purshouse, a medical oncology trainee and the Clinical Outreach and Scotland Lead for the project,…